Urolog. pro Praxi, 2010; 11(5): 247-252

Urinary incontinence in the patients with neurogenic bladder dysfunction

MUDr.Miroslava Romžová, MUDr.Marie Hurtová, MUDr.Jaroslav Pacovský, MUDr.Miloš Broďák, Ph.D.
Urologická klinika FN, Hradec Králové

Many diseases and injury of nervous system causes neurogenic dysfunction of lower urinary tract. The common symptom of these

diseases is urinary incontinence. The extensive exams and special diagnostic tests lead to the diagnosis of the neurogenic bladder.

The treatment could be difficult and takes a lot of time. New surgery techniques and materials could help in their treatment. The followup

is very important because of inscrutable character of the primary neurogenic disease.

Keywords: neurogenic disorders of urinary tract, urgent incontinence, stress incontinence, neurogenic urinary bladder

Published: October 22, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Romžová M, Hurtová M, Pacovský J, Broďák M. Urinary incontinence in the patients with neurogenic bladder dysfunction. Urol. praxi. 2010;11(5):247-252.
Download citation

References

  1. Hanuš T. Dysfunkce dolních močových cest. In: Dvořáček J. Urologie III. ISV Praha, 1998: 1307-1333.
  2. Madersbacher H. The neuropathic uretra: urethrogram and pathophysiologic aspects. Eur Urol, 1977; 3: 321-332. Go to original source... Go to PubMed...
  3. Schröder A, Abrams P, Andersson K-E, Artibani W, Chapple CR, Drake MJ, Hampel C, Neisius A, Tubaro A, Thüroff JW. Guidelines on Urinary Incontinence. European association of Urology, 2010; 56
  4. Stohrer M, Castro-Diaz D, Chartier-Kastler E, Krammer G, Mattiason A, Wyndaele JI. Guidelines EAU pro neurogenní dysfunkci dolních močových cest. Urol List 2008; 6(2): 97-120.
  5. Wein AJ. Neuromuscular dysfunction of the lower urinary tract. In: Walsh PC, Retik AB, Stamey TA, Vaughan ED. Campbell´s urology. Sixth edition 1992; 1: 573-642.
  6. Zámečník L. Inkontinence moči. Med Prax, 2005; 5(5): 227-230.
  7. Rickwood AM. Assessment and conservative management of the neuropathic bladder. Semin Pediatr Surg, 2002; 11(2): 108-119. Go to original source... Go to PubMed...
  8. Zderic SA, Levin RM, Wein AJ. Voiding function and dysfunction: A - relevant anatomy, physiology and pharmacology, and molecular biology. In: Gillenwater JY, Grayhack JT, Howards SS, Duckett JD. Adult and pediatric urology. Chicago, 1999: 1159-1219.
  9. Dzvinčuk P, Müller O, Látalová E. Inkontinence moči z pohledu gynekologa. Interní Med., 2008; 10(2): 90-95.
  10. Krhut J, Mainer K, Zapletalová O. Terapie dysfunkcí močových cest u pacientů s roztroušenou sklerózou. Neurol Prax, 2002; 1: 41-45.
  11. Tran K, Levin RM, Mousa SA. Behavioral intervention versus pharmacotherapy or their combinations in the management of overactive bladder dysfunction. Adv Urol, 2009; 15. Go to original source... Go to PubMed...
  12. Zachoval R, Záleský M, Heráček J, Lukeš M, Kuncová J, Urban M. Neurogenní dysfunkce dolních močových cest. Neurol Prax, 2004; 4: 226-230.
  13. Broďák M, Morávek P, Stefan H, Louda M, Pacovský J. Augmentace močového měchýře u refrakterního hyperaktivního měchýře. Urol Prax 2007; 2: 85-86.
  14. Krhut J. Botulotoxin - struktura, mechanizmus účinku a klinické použití. Urolog. pro Praxi, 2006; 5: 278-282.
  15. Schurch B, Denys P, Kozma CM, Reese PR, Slaton T, Barron RL. Botulinum toxin A improves the quality of life of patients with neurogenic urinary incontinence. Eur Urol, 2007; 52: 850-859. Go to original source... Go to PubMed...
  16. Mariappan P, Alfasso A, Ballantyne Z, Grant A, N´Dow J. Duloxetine, a Serotonin and Noradrenaline reaptake inhibitor (SNRI) for the treatment of stress urinary incontinence: A systematic review. European Urology, 2007; 51: 67-74. Go to original source... Go to PubMed...
  17. Vrtal R, Záťura F, Vidlář A. První zkušenosti s užitím duloxetinu u pacientek se stresovou inkontinencí. Ces Urol, 2006; 1: 40-43.
  18. Zinner NR, Koke SC, Viktrup L. Farmakoterapie stresové inkontinence moči. Současné a budoucí možnosti. Drugs, 2004; 64(14): 1503-1516. Go to original source... Go to PubMed...
  19. Mitterberger M, Pinngera GM, Marksteiner R, Margreiter E, Fussenegger M, Frauscher F, Ulmer H, Hering S, Bartch G, Strasser H. Adult stem cell therapy of female stress urinary incontinence. European Urology, 2008; 53: 169-175. Go to original source... Go to PubMed...
  20. Djakovic N, Hubert J, Nyarangi-Dix J, Hohenfellner M. Artificial sphincter for the treatment of incontinence, Urologe A, 2010; 49(4): 515-524. Go to original source... Go to PubMed...




Urology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.